Julianne Moore’s portrayal of a woman with early onset Alzheimer’s in the movie "Still Alice" required extensive research ...

The medication lecanemab was approved by the U.S. FDA to treat Alzheimer’s disease in 2023. Like all medications, lecanemab comes with the potential for side effects, including amyloid-related imaging ...

NEWTON, Mass., July 28, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (ABOS) (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic ...

The battle against Alzheimer’s disease continues to evolve as research uncovers more complex relationships between lifestyle factors and brain health. While exercise has long dominated conversations ...

When most people think about the early warning signs of Alzheimer’s disease, memory lapses immediately come to mind. Forgetting names, misplacing keys, or struggling to recall recent conversations are ...

After a string of graffiti incidents plagued an assisted living facility in South Tacoma, residents at the center came together last week to paint a mural to cover up the graffiti and fundraise to ...

Eisai to Present Data on Lecanemab Continued Treatment, Subcutaneous Initiation Dosing, and Real-World Experience at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference By Eisai Inc. Nov ...